SB 88 Indiana Senate · 2022 Regular Session

Prescription drug rebates and pricing.

Summary
Provides that, for individual health insurance coverage, the defined cost sharing for a prescription drug be calculated at the point of sale and based on a price that is reduced by an amount equal to at least 85% of all rebates received by the insurer in connection with the dispensing or administration of the prescription drug. Requires that, for group health insurance coverage, an insurer: (1) pass through to a plan sponsor 100% of all rebates received or estimated to be received by the insurer concerning the dispensing or administration of prescription drugs to the covered individuals of the plan sponsor; (2) provide a plan sponsor, at the time of contracting, the option of calculating defined cost sharing for covered individuals of the plan sponsor at the point of sale based on a price that is reduced by some or all of the rebates received or estimated to be received by the insurer concerning the dispensing or administration of the prescription drug; and (3) disclose specified information to the plan sponsor. Allows the department of insurance to enforce the provisions and impose a civil penalty.
Bill status passed 3 of 5 stages cleared
Introduction
Jan 2022
Committee Review
Feb 2022
Senate Passage
Jan 2022
House Passage
Governor
Introduced Jan 4, 2022 Last action Feb 10, 2022
Floor votes · Senate Jan 31, 2022

How they voted

3016
Passed
Total votes 46
Jan 31, 2022
D Democratic10
8 Yea 2 Nay
80% Yea
R Republican36
22 Yea 14 Nay
61% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
14
Key actions
2
Committee
2
Amendments
1
Feb 1, 2022
Committee
Referred to the House
upper
Jan 31, 2022
Upper · Passed
Third reading: passed; Roll Call 102: yeas 31, nays 18
upper
Jan 27, 2022
Amended
Amendment #6 (Charbonneau) prevailed; voice vote
upper
Jan 20, 2022
Upper · Passed
Committee report: do pass, adopted
upper
3 primary · 4 co-sponsors

Sponsors